61 related articles for article (PubMed ID: 18192965)
1. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
Lee CH; Espinosa I; Jensen KC; Subramanian S; Zhu SX; Varma S; Montgomery KD; Nielsen TO; van de Rijn M; West RB
Mod Pathol; 2008 May; 21(5):531-9. PubMed ID: 18192965
[TBL] [Abstract][Full Text] [Related]
2. Keratin-Positive Giant Cell-Rich Tumor of Bone Harboring an
Patton A; Ilaslan H; Armstrong SM; Bakhshwin A; Cheng YW; Minhas F; Fritchie KJ
Int J Surg Pathol; 2024 May; 32(3):556-564. PubMed ID: 37461232
[TBL] [Abstract][Full Text] [Related]
3. Histones and their practical application in bone tumors: Do I always need them?
Reith JD
Hum Pathol; 2024 May; 147():92-100. PubMed ID: 38307341
[TBL] [Abstract][Full Text] [Related]
4. Coxal giant cell-rich tumour harbouring an NUTM1 gene fusion: a new molecular subtype of giant cell tumour of bone?
Fattori A; Reita D; Brinkert D; Willaume T; Gantzer J; Karanian M; Lhermitte B; Wolf T; De Pinieux G; Weingertner N
Histopathology; 2024 May; 84(6):1072-1075. PubMed ID: 38229224
[No Abstract] [Full Text] [Related]
5. Keratin-Positive Giant Cell-Rich Tumor: A Review and Update.
Nishio J; Nakayama S; Koga K; Aoki M
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792018
[TBL] [Abstract][Full Text] [Related]
6. Biphasic synovial sarcoma with myoepithelial features: a distinctive variant with a predilection for the foot.
Almohsen SS; Griffin AM; Dickson BC; Demicco EG
Virchows Arch; 2023 Oct; ():. PubMed ID: 37864652
[TBL] [Abstract][Full Text] [Related]
7. Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors.
van IJzendoorn DGP; Matusiak M; Charville GW; Spierenburg G; Varma S; Colburg DRC; van de Sande MAJ; van Langevelde K; Mohler DG; Ganjoo KN; Bui NQ; Avedian RS; Bovée JVMG; Steffner R; West RB; van de Rijn M
Clin Cancer Res; 2022 Nov; 28(22):4934-4946. PubMed ID: 36007098
[TBL] [Abstract][Full Text] [Related]
8. A novel model to culture cells from giant cell tumor of bone using three-dimensional (3D) polycaprolactone scaffold.
Estrada-Villaseñor E; Valdés-Flores M; Meneses-García A; Silva-Bermudez P; Pichardo-Bahena R; Ostoa-Saloma P; Mercado-Celis G; Delgado-Cedillo ED; Olivos-Meza A; Landa-Solís C
Eng Life Sci; 2021 Sep; 21(8-9):539-543. PubMed ID: 34584518
[TBL] [Abstract][Full Text] [Related]
9. Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions.
Hui M; Uppin SG; Kumar KK; Radhika S; Chandrasekhar P; Rao KN
Turk Patoloji Derg; 2022; 38(1):9-15. PubMed ID: 34514571
[TBL] [Abstract][Full Text] [Related]
10. Can p63 serve as a biomarker for diagnosing giant cell tumor of bone? A systematic review and meta-analysis.
Wan Z; Lee CW; Yuan S; Lee OK
Sao Paulo Med J; 2020; 138(5):393-399. PubMed ID: 33111920
[TBL] [Abstract][Full Text] [Related]
11. Primary hemosiderotic fibrolipomatous tumor in bone: a case report and review of the literature.
Hou W; Li C; Guo C; Zhang L; Meng X; Liu Q; Wang J
Int J Clin Exp Pathol; 2018; 11(5):2497-2505. PubMed ID: 31938362
[No Abstract] [Full Text] [Related]
12. Wide Resection and Iliac Crest Arthrodesis for Multiply Recurrent Giant Cell Tumor of First Metatarsal.
Golz A; Murphy M; Nystrom L; Schiff A
Case Rep Orthop; 2018; 2018():4521841. PubMed ID: 30631621
[TBL] [Abstract][Full Text] [Related]
13. Case Reports of a Giant Cell Reparative Granuloma and a Giant Cell Tumor on Temporal Bone.
Dai WY; Tian C; Liu L
Chin Med J (Engl); 2018 Sep; 131(18):2254-2256. PubMed ID: 30203809
[No Abstract] [Full Text] [Related]
14. Central giant cell lesion of the mandible in a 2-year old girl.
Oda T; Sue M; Okada Y; Kanri Y; Ono J; Ogura I
Imaging Sci Dent; 2017 Sep; 47(3):209-213. PubMed ID: 28989904
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of local recurrence in giant cell tumour of bone: what can we do?
He Y; Zhang J; Ding X
Radiol Med; 2017 Jul; 122(7):505-519. PubMed ID: 28271361
[TBL] [Abstract][Full Text] [Related]
16. Expressions and clinical significance of factors related to giant cell tumor of bone.
Li C; Zheng X; Ghert M; Li H; Wang B; Feng Y
Int J Clin Exp Med; 2015; 8(12):22509-14. PubMed ID: 26885235
[TBL] [Abstract][Full Text] [Related]
17. Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
Mukaihara K; Suehara Y; Kohsaka S; Akaike K; Tanabe Y; Kubota D; Ishii M; Fujimura T; Kazuno S; Okubo T; Takagi T; Yao T; Kaneko K; Saito T
PLoS One; 2016; 11(2):e0148401. PubMed ID: 26863138
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges.
Wan-Ibrahim WI; Singh VA; Hashim OH; Abdul-Rahman PS
Mol Med; 2016 Mar; 21(1):861-872. PubMed ID: 26581086
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.
Conceição AL; Babeto E; Candido NM; Franco FC; de Campos Zuccari DA; Bonilha JL; Cordeiro JA; Calmon MF; Rahal P
J Cancer; 2015; 6(7):593-603. PubMed ID: 26078788
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
